SOADOR
UTHR icon

State of Alaska Department of Revenue’s United Therapeutics UTHR Stock Holding History

State of Alaska Department of Revenue’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.89M Sell
18,264
-1,788
-9% -$1.01M 0.1% 165
2026
Q1 		$11.9M Buy
20,052
+6,320
+46% +$3.15M 0.13% 128
2025
Q4 		$6.69M Sell
13,732
-675
-5% -$314K 0.07% 235
2025
Q3 		$6.04M Sell
14,407
-5,125
-26% -$1.72M 0.06% 282
2025
Q2 		$5.61M Buy
19,532
+2,840
+17% +$849K 0.06% 298
2025
Q1 		$5.14M Buy
16,692
+135
+0.8% +$46.3K 0.06% 309
2024
Q4 		$5.84M Sell
16,557
-85
-0.5% -$31.2K 0.07% 272
2024
Q3 		$5.96M Buy
16,642
+350
+2% +$118K 0.06% 301
2024
Q2 		$5.19M Sell
16,292
-265
-2% -$70.1K 0.06% 333
2024
Q1 		$3.8M Buy
16,557
+10,025
+153% +$2.26M 0.04% 450
2023
Q4 		$1.44M Sell
6,532
-515
-7% -$119K 0.02% 824
2023
Q3 		$1.59M Sell
7,047
-225
-3% -$51.8K 0.02% 724
2023
Q2 		$1.6M Sell
7,272
-472
-6% -$105K 0.02% 752
2023
Q1 		$1.73M Sell
7,744
-95
-1% -$23.4K 0.02% 716
2022
Q4 		$2.18M Buy
7,839
+31
+0.4% +$7.83K 0.03% 608
2022
Q3 		$1.63M Buy
7,808
+1,303
+20% +$291K 0.02% 702
2022
Q2 		$1.53M Sell
6,505
-9,253
-59% -$1.88M 0.02% 756
2022
Q1 		$2.83M Buy
15,758
+2,648
+20% +$504K 0.03% 534
2021
Q4 		$2.83M Sell
13,110
-451
-3% -$88.5K 0.03% 569
2021
Q3 		$2.5M Sell
13,561
-2,748
-17% -$541K 0.03% 609
2021
Q2 		$2.92M Sell
16,309
-1,814
-10% -$345K 0.03% 534
2021
Q1 		$3.03M Buy
18,123
+2,081
+13% +$347K 0.03% 499
2020
Q4 		$2.43M Buy
16,042
+2,345
+17% +$308K 0.03% 535
2020
Q3 		$1.38M Buy
13,697
+2,469
+22% +$271K 0.02% 717
2020
Q2 		$1.36M Buy
11,228
+3,667
+48% +$413K 0.02% 726
2020
Q1 		$716K Buy
7,561
+345
+5% +$32.8K 0.01% 924
2019
Q4 		$635K Sell
7,216
-580
-7% -$51K 0.01% 1189
2019
Q3 		$621K Buy
7,796
+3,145
+68% +$253K 0.01% 1149
2019
Q2 		$363K Sell
4,651
-7,721
-62% -$722K 0.01% 1220
2019
Q1 		$1.45M Buy
12,372
+7,813
+171% +$910K 0.03% 596
2018
Q4 		$496K Buy
4,559
+87
+2% +$10.1K 0.01% 970
2018
Q3 		$571K Sell
4,472
-248
-5% -$30.7K 0.01% 1018
2018
Q2 		$534K Buy
4,720
+1,350
+40% +$148K 0.01% 1040
2018
Q1 		$378K Buy
3,370
+770
+30% +$97.8K 0.01% 1117
2017
Q4 		$384K Buy
+2,600
New +$331K 0.01% 906

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

State of Alaska Department of Revenue's UTHR Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its United Therapeutics (UTHR) stake by 8.9% in Q2 2026, selling an estimated $1.01M and leaving 18,264 shares worth $9.89M. The position accounts for 0.1% of the portfolio, ranked #165.

State of Alaska Department of Revenue first reported a position in UTHR in Q4 2017 and has held it in 35 quarters since. The position peaked at $11.9M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • State of Alaska Department of Revenue held 18,264 shares of United Therapeutics worth $9.89M as of Q2 2026.
  • State of Alaska Department of Revenue sold 1,788 United Therapeutics shares in Q2 2026, an estimated $1.01M.
  • United Therapeutics made up 0.1% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #165 holding.
  • State of Alaska Department of Revenue first reported a position in United Therapeutics in Q4 2017 and has held it in 35 quarters since.
  • State of Alaska Department of Revenue's United Therapeutics position peaked at $11.9M in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.